iThe current values are delayed, open demat account for live values.
Nifty Pharma
Nifty Pharma Performance
Day Range
- Low 14989.55
- High 15078.6
- Open15,032.90
- Previous Close15,017.40
- Dividend Yeild0.87%
-
High
15078.6
-
Low
14989.55
-
Day Open Price
15032.9
-
Prev Close
15017.4
-
P/E
31.68
Nifty Pharma chart
Stocks Performance
Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
| Company | Market Cap | Market Price | Volume | Sector |
|---|---|---|---|---|
| Abbott India Ltd | ₹48111 Cr |
₹22760
(1.44%)
|
12176 | Pharmaceuticals |
| Cipla Ltd | ₹95167 Cr |
₹1164.8
(0.72%)
|
1937874 | Pharmaceuticals |
| Glaxosmithkline Pharmaceuticals Ltd | ₹26059 Cr |
₹1532.3
(2.08%)
|
87094 | Pharmaceuticals |
| Sanofi India Ltd | ₹16344 Cr |
₹7066.85
(8.02%)
|
13436 | Pharmaceuticals |
| Pfizer Ltd | ₹17549 Cr |
₹3866.1
(1.04%)
|
29800 | Pharmaceuticals |
Nifty Pharma Sector Performance
Top Performing
| Sector Name | Percentage Change |
|---|---|
| Diamond, Gems and Jewellery | 0.91 |
| Ceramic Products | 0.22 |
| Gas Distribution | 0.07 |
| Finance | 0.01 |
Under Performing
| Sector Name | Percentage Change |
|---|---|
| IT - Hardware | -1.06 |
| Leather | -0.03 |
| Healthcare | -0.19 |
| Dry cells | -1.7 |
NIFTY Pharma
The pharma industry’s performance is depicted in the NIFTY Pharma Index. 20 NSE-listed companies are included in the Index (NSE).
The level of the NIFTY Pharma Index shows the overall free float market valuation of all the companies included in the benchmark with a specific base market cap value. This index is calculated by using the free float market capitalization approach.
The NIFTY Pharma Index is utilized for several things, including creating structured products, ETFs, and index funds, as well as benchmarking investment portfolios.
The index was introduced in July 2005, with a reference level of 1000 and a baseline date of January 1st, 2001. The index is recalibrated every two years.
NIFTY Pharma Scrip Selection Criteria
● The companies under evaluation must be NIFTY 500 members.
● A shortfall amount of stocks will be chosen from the world of securities classified within the leading 800, predicated both on total daily turnover and daily total full market capitalization.
● Businesses must be engaged with the pharmaceutical industry.
● The company’s investing velocity in the previous six months must have been at least 90%.
● The company must have a six-month listing record. If a firm launches an IPO and meets the standard qualifying conditions for the index for a 3-month term rather than a period of 6 months, it will become qualified for inclusion within the index.
● Depending on the companies’ free-float market capitalization, the final 20 companies will be chosen.
● When making the final decision, priority will be given to firms that can be traded in the futures and options part of the NSE.
Other Indices
| Indices Name | Price | Price Change (% change) |
|---|---|---|
| India VIX | 11.27 | 0.37 (3.39%) |
| Nifty 10 Yr Benchmark G-Sec | 2195.82 | 0.86 (0.04%) |
| Nifty 10 Yr Benchmark G-Sec (Clean Price) | 871.66 | 0.17 (0.02%) |
| Nifty 100 | 19618.85 | 12 (0.06%) |
| Nifty 100 Equal Weight | 23247.55 | 61.85 (0.27%) |
Faqs
Which is the current best pharma company in India?
Cipla, Alkem, Sun Pharma, Torrent Pharma, and Dr. Reddy’s Laboratories are the current best pharma-based companies in India in terms of market capitalization.
How do I calculate NIFTY Pharma?
Each stock’s weightage in the index is determined according to its free-float market capitalization, except for the top three stocks, whose combined weight cannot exceed 62% at the point of rebalancing, and no separate stock should have a weightage greater than 33%. Index Rebalancing: The index is recalibrated every two years.
How many companies are available in the NIFTY 50 index?
The Nifty 50 Index comprises a total of 4 businesses from the Nifty Pharma Index. These companies are Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Divi’s Laboratories Ltd., and Sun Pharmaceuticals Ltd.
Is it risky to invest in pharma stocks?
Buying stocks of pharmaceutical companies can sometimes be risky due to the high costs and lengthy time between pharmaceutical research and approval (considering that the drug research procedure is successful and regulatory permission is given).
Should I start investing in pharmaceutical stocks?
Despite the instability, pharma businesses might be appealing to long-term traders. Traders can earn higher returns when they purchase at the correct time because the pharmaceutical industry is growing rapidly and has become increasingly important to daily life.
What is the cause behind the impulsive growth of the pharma sector?
Several pharma companies have experienced a spike in revenue due to authorities in the USA and other nations approving immunizations against the COVID-19 virus. The need for pharmaceutical stocks is rising; therefore, now is an excellent time to buy them.
What are the few major uses of NIFTY Pharma?
There are several uses of NIFTY Pharma in real-time. Still, the few major ones include the creation and implementation of structured products, index funds, ETFs, and benchmarking or evaluating mutual funds portfolios.
Latest News
- Sep 26, 2023
The IPO of Mangalam Alloys Ltd closed on Monday, 25th September 2023. The IPO had opened for subscription on 21st September 2023. Let us look at the final subscription status of Mangalam Alloys Ltd at the close of subscription on 25th September 2023.
- Sep 26, 2023
Strong listing for Chavda Infra IPO, but fails to hold on
- Sep 25, 2023
The National Stock Exchange (NSE) is considering a significant shift in its trading hours, potentially introducing extended sessions for equity derivatives.
- Sep 25, 2023
Delta Corp Ltd, a prominent gaming company, saw its stock plummet by 20% during the intraday session on the Bombay Stock Exchange (BSE), touching its 52-week low of ₹140.20.
Latest Blogs
In a significant development for India's financial landscape, JP Morgan Chase & Co. recently announced its decision to include Indian government bonds in its emerging markets bond index, starting from June 2024. This momentous move holds the promise of attracting substantial foreign investments, potentially injecting up to $25 billion into India's domestic government securities market.
- Sep 25, 2023
Why to go for Loss to Profit Business? Potential for Rapid Growth: Companies that have turned around from losses to profits often have room for rapid growth. As they fine-tune their operations and strategies, they may experience significant increases in revenue and profitability. Undervaluation: Market sentiment may lag behind a company's actual performance.
- Sep 25, 2023
- Sep 25, 2023
Nifty started trading for the new week on a flat note and witnessed a continuation of the corrective mode in the first hour of trade. However, the index recovered from its support of 19600 and ended around the previous session’s close.
- Sep 25, 2023
